KPV Peptide

Our KPV peptide is intended for researchers investigating inflammatory signaling, barrier-related biological processes, and immune signaling mechanisms. This tripeptide, derived from the C-terminal fragment of alpha-MSH, is supplied lyophilized to preserve bioactivity and support standardized reconstitution.
Production follows GMP principles, and every batch is verified by independent HPLC and MS analyses. Each batch includes a specific Certificate of Analysis documenting purity levels and analytical conditions, supporting transparent reporting and internal quality systems.
KPV is widely explored in in-vitro models examining epithelial barrier signaling, cytokine signaling, and tissue-response mechanisms. Clear "For Research Use Only" designation, combined with full batch traceability, makes it a strong choice for laboratories conducting mechanistic work in cellular and immunological research fields.
Disclaimer
All products offered by HG Wellness Peptides are strictly intended for laboratory, scientific, and research purposes only. They are NOT for human consumption, clinical use, veterinary application, diagnostic procedures, or direct administration of any kind.
None of the statements on this website have been evaluated or approved by the U.S. Food and Drug Administration (FDA). These products are not medical devices, supplements, or drugs, and are not intended to diagnose, treat, cure, or prevent any disease, condition, or physical ailment.
By purchasing from this website, the buyer acknowledges and agrees that they are at least 21 years of age and are fully qualified, trained, and equipped to handle research chemicals in accordance with applicable laws, health, and safety protocols. HG Wellness Peptides assumes no liability for any direct, indirect, or consequential damages resulting from improper handling, misuse, or unauthorized application of these products.
Reach Out Anytime
Send questions about peptides, orders, or documentation, and our team responds promptly with clear, evidence-based guidance.
